Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact. - Test2 - elhamkhani - TriplyDB

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact.

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact.

http://www.wikidata.org/entity/Q34493286

about

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013.Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis.Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan.Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study.Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.Using Facebook to Recruit Young Australian Men Into a Cross-Sectional Human Papillomavirus Study.Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus.Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts.Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa

P2860

Q33682928-41491E03-F571-4648-B674-CB9BC792E36D Q35678090-FD90C1A5-0BF4-4B6B-9F6F-5C1C93817E03 Q36418117-1A5CF749-4091-46A3-B2DA-82A1A8C8DCB0 Q36964366-5B0D13A4-D657-4604-B821-799C28A8A530 Q37742357-DB96FC70-3FD8-443A-9AE8-96FD55F7CA14 Q38893196-F4A5154E-6CAC-4AD9-9B51-15B32A448AD3 Q40056191-4C1D6838-3867-4EDB-B039-058E3671B39D Q40805660-23555CFE-BF36-4669-BB29-A2F3AA33E288 Q47120716-3F5182B1-E72A-41DB-9C3B-8AD67E0496A2 Q47315433-4FC98454-26AD-460C-B952-5065EBE5E3C4 Q47599112-9B217D66-B4BE-4203-80B6-209CE96050E6 Q58716858-F2C375A2-89B9-4B6B-A19D-419579B12A09

P2860

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact.

http://www.wikidata.org/entity/Q34493286

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@ast

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@en

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@nl

type

label

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@ast

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@en

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@nl

prefLabel

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@ast

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@en

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@nl

P1433

Q34493286-90D6F347-6E6A-4C95-96C3-0A82BD6D2B55

P1476

Q34493286-8F2F3844-C487-4459-9788-52C1C2108EF8

P2093

Q34493286-0ED197C8-A3F7-4494-8F5F-0E69E82FA710

Q34493286-4150F523-D895-43C1-890B-38D2560BDC3B

Q34493286-4ADFBB1E-E69E-49B5-8F8C-D470C047A5D0

Q34493286-5C1EEA63-C7E1-4DBD-8E82-67317DE00AED

Q34493286-691E2B4C-A7DF-4FA1-AEC4-941012B95994

Q34493286-6F7746D3-517B-4C4B-AE3D-AB693CC7401E

Q34493286-82053516-46A7-4E02-B5CD-214BE740919A

Q34493286-87336093-2CC5-4B41-9EA2-33A722BFE61E

P2860

Q34493286-08F4B658-C4E6-4D22-A31F-9A34C3F05CD8

Q34493286-1C92D328-54AD-48D9-99B8-6985D81AF1E1

Q34493286-1DB912AC-D7AB-4858-ACB5-58DBF90A5E99

Q34493286-2DBBA97B-1D6F-4D7F-8769-4E22E676BD31

Q34493286-31A5F367-8568-4084-908A-B7D9ECA416B0

Q34493286-43C3F111-E062-4D49-81D0-860AFC580446

Q34493286-44893157-1A2E-44E8-9785-817095459163

Q34493286-486A4976-350D-4328-8A28-156C824E2363

Q34493286-4F7791F8-1DA7-4CB1-893B-0CBEAAB5E8B8

Q34493286-6030B09F-F31A-455C-BCAD-8EE04EF39F99

P2888

Q34493286-2091AEA3-38A8-4A0D-BEAC-47075E78C85B

P304

Q34493286-2A2E9F68-F545-4E44-980C-0DFD7DFA646F

P31

Q34493286-C2E47E45-BE95-4B21-BF4C-FB621A162D49

P356

Q34493286-62778302-11EE-4FD3-91AF-446C9118F7D4

P478

Q34493286-0623E28F-9A6F-4F62-B1EA-C00EF8BB536F

P50

Q34493286-CF283E14-CCD8-49D1-9D5C-10894F993C38

P577

Q34493286-2727BA5A-561A-458C-BFBC-1E893DA88B69

P5875

Q34493286-9AE5AF9B-CE3E-4A08-8198-0C1DC851407A

P6179

Q34493286-CD224BB7-9DAB-476B-878D-4DB648948BF8

P698

Q34493286-413E9646-1E52-47C7-82FF-117E53AC8020

P932

Q34493286-1D7F8C70-68EF-4617-AFA1-5438580D7E4E

P356

1471-2334-13-519

P1433

BMC Infectious Diseases

P1476

Estimation of HPV prevalence i ...... ring of future vaccine impact.

@en

P2093

Alison Potts

http://www.w3.org/2001/XMLSchema#string

Chris Robertson

http://www.w3.org/2001/XMLSchema#string

Heather Cubie

http://www.w3.org/2001/XMLSchema#string

John Love

http://www.w3.org/2001/XMLSchema#string

Kate Cuschieri

http://www.w3.org/2001/XMLSchema#string

Katy Sinka

http://www.w3.org/2001/XMLSchema#string

Kevin G J Pollock

http://www.w3.org/2001/XMLSchema#string

Martin Donaghy

http://www.w3.org/2001/XMLSchema#string

P2860

A review of human carcinogens--Part B: biological agents

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.

HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland.

Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study

Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation.

Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.

Young people and sexual risk-taking behaviour in Central England.

P2888

1471-2334-13-519

P304

519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-13-519

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Kimberley Kavanagh

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258280550

http://www.w3.org/2001/XMLSchema#string

P6179

1003646480

http://www.w3.org/2001/XMLSchema#string

P698

24188790

http://www.w3.org/2001/XMLSchema#string

P932

4228358

http://www.w3.org/2001/XMLSchema#string